NuCana PLC (NCNA)
3.98
+0.02
(+0.51%)
USD |
NASDAQ |
May 01, 16:00
3.85
-0.13
(-3.27%)
Pre-Market: 20:00
NuCana Cash and Short Term Investments (Quarterly): 21.94M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 21.94M |
| September 30, 2023 | 21.72M |
| June 30, 2023 | 31.08M |
| March 31, 2023 | 38.40M |
| December 31, 2022 | 50.72M |
| September 30, 2022 | 56.67M |
| June 30, 2022 | 56.43M |
| March 31, 2022 | 69.04M |
| December 31, 2021 | 81.33M |
| September 30, 2021 | 95.37M |
| June 30, 2021 | 101.61M |
| March 31, 2021 | 108.07M |
| December 31, 2020 | 119.05M |
| September 30, 2020 | 129.51M |
| Date | Value |
|---|---|
| June 30, 2020 | 58.84M |
| March 31, 2020 | 58.88M |
| December 31, 2019 | 68.13M |
| September 30, 2019 | 71.41M |
| June 30, 2019 | 82.59M |
| March 31, 2019 | 91.18M |
| December 31, 2018 | 97.67M |
| September 30, 2018 | 102.08M |
| June 30, 2018 | 106.51M |
| March 31, 2018 | 114.00M |
| December 31, 2017 | 117.17M |
| June 30, 2017 | 20.71M |
| December 31, 2016 | 24.56M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
21.72M
Minimum
Sep 2023
129.51M
Maximum
Sep 2020
69.52M
Average
68.13M
Median
Dec 2019
Cash and Short Term Investments (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 146.94M |
| Biodexa Pharmaceuticals Plc | 7.606M |
| Autolus Therapeutics PLC | 239.57M |
| Mereo BioPharma Group PLC | 57.42M |
| Bicycle Therapeutics PLC | 526.42M |